The article presents modern concepts of “cardiovascular continuum”, where there are stages of heart disease risk factors up to death. The fundamental constant is a magnesium deficiency as a risk factor for endothelial dysfunction. The authors show the way of absorption, distribution of the elimination of magnesium, the regulatory significance of genes, providing its bioavailability. Symptoms of magnesium deficiency on the part of the cardiovascular system are characterized. The authors specify the involvement of magnesium in the develop-ment of metabiological syndrome, the possibilities of correction of its content, respectively, and insulin resis-tance. An anti-arrhythmogenic effect of the drug magnesium – Magnerot - was proven.
metabolic syndrome, insulin resistance, magnesium deficiency.
1. Gorodetskiy V.V., Talibov O.B. Preparaty magniya v meditsinskoy praktike. Malaya entsiklope-diya magniya. Moskva: Medpraktika-M, 2006.
2. Gromova O.A. Magniy i piridoksin: osnovy znaniy. Novye tekhnologii diagnostiki i korrek-tsii defitsita magniya. Obuchayushchie programmy Yunesko. Moskva: RSTs Institut mikroelementov, 2006. C. 3-176.
3. Metabolicheskiy sindrom. Moskva: «MEDpres-inform», 2007.
4. Nechaeva G.M., Yakovlev V.M., Druk I.V., Tikhonova O.V. Narusheniya ritma serdtsa pri nediffe-rentsirovannoy displazii soedinitel´noy tkani. Lechashchiy vrach. 2008. №6. S. 2-7.
5. Rachin A.P., Sergeev A.V., Mikheykina O.V. Defitsit magniya: vozmozhnosti primeneniya preparata magne v6. Farmateka. 2008. №5. S. 54-60.
6. Shevchenko O.P., Praskurnichiy E.A., Shevcheno A.O. Arterial´naya gipertoniya i ozhirenie. Mo-skva: Reofarm, 2006.
7. Barbato J.E., Zuckerbraun B.S., Overbaus M. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and metabolic syndrome. J. Physiol. Heart. Circ. 2005. V. 289. P. 228-236.
8. Caballero A.E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes. Res. 2003. №11. P. 1278-1289.
9. Jellinek H., Takacs E. Morphological aspects of the effects of orotic acid and magnesium. Arzneimit-telforschung. 1995. 45(8). P. 836-842.
10. Rabmouni K., Correia M.L.G., Haynes W.G. Obesity -associated Hypertension. New insights into mechanisms. Hypertension. 2005. V. 45. P. 9-14.
11. Seelig M.S. Metabolic Sindrom-X. A complex of common diseases - diabetes, hypertension, heart disease, dyslipidemia and obesity - marked by insulin resistance and low magnesium/high calcium. Mineral Res. Intern. Tech. Prod. Infor. 2003. №1. R. 11.
